Nadine Kutsch

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Andréas Mackensen, John B.A.G. Haanen, Christian Koenecke et al. · Nature Medicine · 2023 · 261 citations · Full text

Medicine, Immunology, Oncology +17

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia

Carmen Herling, Nima Abedpour, Jonathan M. Weiss et al. · Nature Communications · 2018 · 194 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy

Christian P. Pallasch, Ilya Leskov, Christian Braun et al. · Cell · 2014 · 179 citations · Full text

Medicine, Immunology, Oncology +14

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian P. Pallasch, Michaela Patz, Yoon Jung Park et al. · Blood · 2009 · 158 citations · Full text

Medicine, Molecular Biology, Oncology +17

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +12